Research progress of myocardial strain detection technique in myocardial injury of non-alcoholic fatty liver disease

doi:10.11958/20221772

Abstract

Abstract:

Non-alcoholic fatty liver disease (NAFLD) can lead to myocardial damage and is a risk factor for cardiac insufficiency. Myocardial strain (MS) detection is a new technique that has been rapidly developed in recent years and has become a common tool for quantifying myocardial deformation and diagnosing and predicting subclinical myocardial injury. MS can not only accurately assess local and global myocardial injury, but also detect changes of cardiac function in NAFLD patients with normal ejection fraction. Understanding myocardial injury caused by NAFLD, timely detection, diagnosis and prediction of cardiac dysfunction in patients with NAFLD by MS detection technique are of great clinical significance in preventing the progression of irreversible heart failure. This article reviews the pathophysiological mechanisms of myocardial injury caused by NAFLD, MS detection techniques and the use of MS detection techniques in atria and ventricle in patients with NAFLD.

Key words: non-alcoholic fatty liver disease, echocardiography, doppler, magnetic resonance angiography, myocardial strain, myocardial damage

CLC Number:

R455.1，R445.2

References 35

[1]	HUANG D Q, EL-SERAG H B, LOOMBA R. Global epidemiology of NAFLD-related HCC:trends,predictions,risk factors and prevention[J]. Nat Rev Gastroenterol Hepatol, 2021, 18(4):223-238. doi:10.1038/s41575-020-00381-6.
[2]	TARGHER G, COREY K E, BYRNE C D. NAFLD, and cardiovascular and cardiac diseases:factors influencing risk,prediction and treatment[J]. Diabetes Metab, 2021, 47(2):101215. doi:10.1016/j.diabet.2020.101215.
[3]	TARGHER G, BYRNE C D, TILG H. NAFLD and increased risk of cardiovascular disease:clinical associations,pathophysiological mechanisms and pharmacological implications[J]. Gut, 2020, 69(9):1691-1705. doi:10.1136/gutjnl-2020-320622.
[4]	RIJZEWIJK L J, JONKER J T, VAN DER MEER R W, et al. Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes[J]. J Am Coll Cardiol, 2010, 56(3):225-233. doi:10.1016/j.jacc.2010.02.049.
[5]	HOUGHTON D, ZALEWSKI P, HALLSWORTH K, et al. The degree of hepatic steatosis associates with impaired cardiac and autonomic function[J]. J Hepatol, 2019, 70(6):1203-1213. doi:10.1016/j.jhep.2019.01.035.
[6]	KARAYANNIS G, KITSIOS G, KOTIDIS H, et al. Left atrial remodelling contributes to the progression of asymptomatic left ventricular systolic dysfunction to chronic symptomatic heart failure[J]. Heart Fail Rev, 2008, 13(1):91-98. doi:10.1007/s10741-007-9021-6.
[7]	TARGHER G, MANTOVANI A, GRANDER C, et al. Association between non-alcoholic fatty liver disease and impaired cardiac sympathetic/parasympathetic balance in subjects with and without type 2 diabetes-The Cooperative Health Research in South Tyrol (CHRIS)-NAFLD sub-study[J]. Nutr Metab Cardiovasc Dis, 2021, 31(12):3464-3473. doi:10.1016/j.numecd.2021.08.037.
[8]	LIU B, LI Y, LI Y, et al. Association of epicardial adipose tissue with non-alcoholic fatty liver disease:a meta-analysis[J]. Hepatol Int, 2019, 13(6):757-765. doi:10.1007/s12072-019-09972-1.
[9]	FRACANZANI A L, PISANO G, CONSONNI D, et al. Epicardial Adipose Tissue (EAT) Thickness is associated with cardiovascular and liver damage in nonalcoholic fatty liver disease[J]. PLoS One, 2016, 11(9):e0162473. doi:10.1371/journal.pone.0162473.
[10]	王月, 吴艳凯, 崔彩霞, 等. 心脏MRI应变技术评估高血压患者左室功能[J]. 中国医学影像技术, 2021, 37(5):689-693.
	WANG Y, WU Y K, CUI C X, et al. Cardiac MRI strain technique for evaluation on left ventricular function in patients with hypertension[J]. Chin J med imaging technol, 2021, 37(5):689-693. doi:10.13929/j.issn.1003-3289.2021.05.012.
[11]	WANG R, FANG Z, WANG H, et al. Quantitative analysis of three-dimensional left ventricular global strain using coronary computed tomography angiography in patients with heart failure:comparison with 3T cardiac MR[J]. Eur J Radiol, 2021, 135:109485. doi:10.1016/j.ejrad.2020.109485.
[12]	LI N, LIU T, LIU J, et al. Quantifying myocardial strain of the left ventricle in normal people using feature-tracking based on computed tomography imaging[J]. Diagnostics, 2022, 12(2):329. doi:10.3390/diagnostics12020329.
[13]	LAMACIE M M, THAVENDIRANATHAN P, HANNEMAN K, et al. Quantification of global myocardial function by cine MRI deformable registration-based analysis:comparison with MR feature tracking and speckle-tracking echocardiography[J]. Eur Radiol, 2017, 27(4):1404-1415. doi:10.1007/s00330-016-4514-0.
[14]	马亚南, 孟庆超, 王涵, 等. CT测量左室心肌应变的可重复性及与超声对照的一致性研究[J]. 中华放射学杂志, 2021, 55(11):1147-1152.
	MA Y N, MENG Q C, WANG H, et al. The reproducibility of left ventricular strain measured by CT and its agreement with speckle tracking echocardiography[J]. Chin J Radiol, 2021, 55(11):1147-1152. doi:10.3760/cma.j.cn112149-20210209-00115.
[15]	MILITARU S, PANOVSKY R, HANET V, et al. Multivendor comparison of global and regional 2D cardiovascular magnetic resonance feature tracking strains vs tissue tagging at 3T[J]. J Cardiovasc Magn Reson, 2021, 23(1):54. doi:10.1186/s12968-021-00742-3.
[16]	BAKTIR A O, ŞARLI B, ALTEKIN R E, et al. Non alcoholic steatohepatitis is associated with subclinical impairment in left ventricular function measured by speckle tracking echocardiography[J]. Anatol J Cardiol, 2015, 15(2):137-142. doi:10.5152/akd.2014.5212.
[17]	ALTEKIN R E, CAGLAR B, KARAKAS M S, et al. Evaluation of subclinical left ventricular systolic dysfunction using two-dimensional speckle-tracking echocardiography in patients with non-alcoholic cirrhosis[J]. Hellenic J Cardiol, 2014, 55(5):402-410.
[18]	KARABAY C Y, KOCABAY G, KALAYCI A, et al. Impaired left ventricular mechanics in nonalcoholic fatty liver disease:a speckle-tracking echocardiography study[J]. Eur J Gastroenterol Hepatol, 2014, 26(3):325-331. doi:10.1097/MEG.0000000000000008.
[19]	LEUNG D Y, NG A C. Emerging clinical role of strain imaging in echocardiography[J]. Heart Lung Circ, 2010, 19(3):161-174. doi:10.1016/j.hlc.2009.11.006.
[20]	VOIGT J U, CVIJIC M. 2- and 3-Dimensional myocardial strain in cardiac health and disease[J]. JACC Cardiovasc Imaging, 2019, 12(9):1849-1863. doi:10.1016/j.jcmg.2019.01.044.
[21]	EL AMROUSY D, ELGENDY E, AWAD M E, et al. Three-dimensional speckle tracking echocardiography for early detection of left ventricular dysfunction in children with non-alcoholic fatty liver diseases[J]. Cardiol Young, 2021, 31(4):562-567. doi:10.1017/S104795112000445X.
[22]	WANG Q, MA W, XIA J. Nonalcoholic Fatty Liver Is Associated with further left ventricular abnormalities in patients with type 2 diabetes mellitus:a 3-dimensional speckle-tracking study:nonalcoholic fatty liver and left ventricular abnormalities in type 2 diabetes[J]. J Ultrasound Med, 2018, 37(8):1899-1911. doi:10.1002/jum.14536.
[23]	SONAGLIONI A, CERINI F, CERRONE A, et al. Liver stiffness measurement identifies subclinical myocardial dysfunction in non-advanced non-alcoholic fatty liver disease patients without overt heart disease[J]. Intern Emerg Med, 2022, 17(5):1425-1438. doi:10.1007/s11739-022-02966-2.
[24]	DONG Y, CUI H, SUN L, et al. Assessment of left ventricular function in type 2 diabetes mellitus patients with non-alcoholic fatty liver disease by three-dimensional speckle-tracking echocardiography[J]. Anatol J Cardiol, 2020, 23(1):41-48. doi:10.14744/AnatolJCardiol.2019.66805.
[25]	VANWAGNER L B, WILCOX J E, NING H, et al. Longitudinal association of non-alcoholic fatty liver disease with changes in myocardial structure and function:the cardia study[J]. J Am Heart Assoc, 2020, 9(4):e014279. doi:10.1161/JAHA.119.014279.
[26]	SONAGLIONI A, CERINI F, NICOLOSI G L, et al. Left ventricular strain predicts subclinical atherosclerosis in nonadvanced nonalcoholic fatty liver disease patients[J]. Eur J Gastroenterol Hepatol, 2022, 34(6):707-716. doi:10.1097/MEG.0000000000002375.
[27]	CHANG W, WANG Y, SUN L, et al. Evaluation of left atrial function in type 2 diabetes mellitus patients with nonalcoholic fatty liver disease by two‐dimensional speckle tracking echocardiography[J]. Echocardiography, 2019, 36(7):1290-1297. doi:10.1111/echo.14400.
[28]	KOCABAY G, KARABAY C Y, COLAK Y, et al. Left atrial deformation parameters in patients with non-alcoholic fatty liver disease:a 2D speckle tracking imaging study[J]. Clin Sci (Lond), 2014, 126(4):297-304. doi:10.1042/CS20130298.
[29]	LAI Y H, SU C H, HUNG T C, et al. Association of non-alcoholic fatty liver disease and hepatic fibrosis with epicardial adipose tissue volume and atrial deformation mechanics in a large asian population free from clinical heart failure[J]. Diagnostics (Basel), 2022, 12(4):916. doi:10.3390/diagnostics12040916.
[30]	BEKLER A, GAZI E, ERBAG G, et al. Right ventricular function and its relationship with grade of hepatosteatosis in non-alcoholic fatty liver disease[J]. Cardiovasc J Afr, 2015, 26(3):109-113. doi:10.5830/CVJA-2014-068.
[31]	SUNBUL M, KIVRAK T, DURMUS E, et al. Nonalcoholic steatohepatitis score is an independent predictor of right ventricular dysfunction in patients with nonalcoholic fatty liver disease[J]. Cardiovasc Ther, 2015, 33(5):294-299. doi:10.1111/1755-5922.12145.
[32]	TEN HOVE M, NEUBAUER S. MR spectroscopy in heart failure—clinical and experimental findings[J]. Heart Fail Rev, 2007, 12(1):48-57. doi:10.1007/s10741-007-9003-8.
[33]	HALLSWORTH K, HOLLINGSWORTH K G, THOMA C, et al. Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease[J]. J Hepatol, 2013, 58(4):757-762. doi:10.1016/j.jhep.2012.11.015.
[34]	RÜSSEL I K, BROUWER W P, GERMANS T, et al. Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thickness[J]. J Cardiovasc Magn Reson, 2011, 13(1):3. doi:10.1186/1532-429X-13-3.
[35]	HAMMOUDA K, KHALIFA F, ABDELTAWAB H, et al. A new framework for performing cardiac strain analysis from cine MRI imaging in mice[J]. Sci Rep, 2020, 10(1):7725. doi:10.1038/s41598-020-64206-x.